Blockade of IDO inhibits nasal tolerance induction
- PMID: 17617580
- DOI: 10.4049/jimmunol.179.2.894
Blockade of IDO inhibits nasal tolerance induction
Abstract
The amino acid tryptophan is essential for the proliferation and survival of cells. Modulation of tryptophan metabolism has been described as an important regulatory mechanism for the control of immune responses. The enzyme IDO degrades the indole moiety of tryptophan, not only depleting tryptophan but also producing immunomodulatory metabolites called kynurenines, which have apoptosis-inducing capabilities. In this study, we show that IDO is more highly expressed in nonplasmacytoid dendritic cells of the nose draining lymph nodes (LNs), which form a unique environment to induce tolerance to inhaled Ags, when compared with other peripheral LNs. Upon blockade of IDO during intranasal OVA administration, Ag-specific immune tolerance was abrogated. Analysis of Ag-specific T cells in the LNs revealed that inhibition of IDO resulted in enhanced survival at 48 h after antigenic stimulation, although this result was not mediated through alterations in apoptosis or cell proliferation. Furthermore, no differences were found in CD4(+) T cells expressing FoxP3. Our data suggest that the level of IDO expression in dendritic cells, present in nose draining LNs, allows for the generation of a sufficient number of regulatory T cells to control and balance effector T cells in such a way that immune tolerance is induced, whereas upon IDO blockade, effector T cells will outnumber regulatory T cells, leading to immunity.
Similar articles
-
Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.Gut. 2010 May;59(5):595-604. doi: 10.1136/gut.2009.185108. Gut. 2010. PMID: 20427394
-
Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells.J Immunol. 2005 May 1;174(9):5279-87. doi: 10.4049/jimmunol.174.9.5279. J Immunol. 2005. PMID: 15843524
-
Early events in peripheral regulatory T cell induction via the nasal mucosa.J Immunol. 2003 Nov 1;171(9):4592-603. doi: 10.4049/jimmunol.171.9.4592. J Immunol. 2003. PMID: 14568933
-
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.Immunol Rev. 2008 Apr;222:206-21. doi: 10.1111/j.1600-065X.2008.00610.x. Immunol Rev. 2008. PMID: 18364004 Review.
-
Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.Curr Drug Metab. 2007 Apr;8(3):273-82. doi: 10.2174/138920007780362536. Curr Drug Metab. 2007. PMID: 17430115 Review.
Cited by
-
Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study.Clin Transl Allergy. 2011 Dec 12;1(1):17. doi: 10.1186/2045-7022-1-17. Clin Transl Allergy. 2011. PMID: 22410120 Free PMC article.
-
Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.Adv Exp Med Biol. 2017;1036:91-104. doi: 10.1007/978-3-319-67577-0_7. Adv Exp Med Biol. 2017. PMID: 29275467 Free PMC article. Review.
-
Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase.World J Gastroenterol. 2010 Feb 7;16(5):636-40. doi: 10.3748/wjg.v16.i5.636. World J Gastroenterol. 2010. PMID: 20128035 Free PMC article.
-
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.Trends Immunol. 2013 Mar;34(3):137-43. doi: 10.1016/j.it.2012.10.001. Epub 2012 Oct 25. Trends Immunol. 2013. PMID: 23103127 Free PMC article. Review.
-
mRNA-delivery of IDO1 suppresses T cell-mediated autoimmunity.Cell Rep Med. 2024 Sep 17;5(9):101717. doi: 10.1016/j.xcrm.2024.101717. Epub 2024 Sep 6. Cell Rep Med. 2024. PMID: 39243754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous